$ULBI Cashflow Statement | Understand Stock

$ULBI

$6.36 +$0.35 (5.82%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
OPERATING ACTIVITIES:
Net income
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation
Amortization of intangible assets
Intangible asset impairment
Amortization of financing fees
Debt modification expense
Stock-based compensation
Deferred income tax expense
Gain on litigation settlement

Deferred income tax expense
Accounts receivable
Inventories
Prepaid expenses and other assets
Income taxes receivable and payable
Accounts payable and other liabilities
Net cash provided by operating activities
INVESTING ACTIVITIES:
Purchase of Excell, net of cash acquired
UEHC
Total purchase of Excell, net of cash acquired
Purchase of Electrochem
Purchases of property, plant and equipment
Proceeds from sale of equipment
Net cash used in investing activities

FINANCING ACTIVITIES:
Borrowings on credit facility
Payment of credit facilities
Payments on credit facilities
Payment of debt issuance costs
Proceeds from exercise of stock options
Tax withholdings on stock-based awards
Net cash used in financing activities
Effect of exchange rate changes on cash
Effect of exchange rate changes on cash
INCREASE (DECREASE) IN CASH
Cash - Beginning of year
Cash - End of year
Supplemental cash flow information:
Construction in process in accounts payable
Income taxes paid
Interest paid

Comments